TrialEuropean heart journal2018

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.

Michael D Ezekowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.